Integra LifeSciences Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Integra LifeSciences (IART) Tops Q3 EPS by 3c, Updates FY Guidance
October 24, 2019 6:15 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.68, $0.03 better than the analyst estimate of $0.65. Revenue for the quarter came in at $379.1 million versus the consensus estimate of $376.69 million.
GUIDANCE:
Integra LifeSciences sees FY2019 EPS of $2.70-$2.75, versus the consensus of $2.73.... More
